Long-term sustainability of response to upadacitinib among patients with active rheumatoid arthritis refractory to biological treatments: results up to 5 years from SELECT-BEYOND.
Ronald F Van VollenhovenStephen HallAlvin F WellsSebastian MeerweinYanna SongOishi TanjinatusRoy M FleischmannPublished in: RMD open (2024)
NCT02706847.